Ugur Sahin, BioNTech CEO (AP Images)
Covid-19 roundup: BioNTech offers data showing Pfizer-partnered vaccine protects against variant; Novavax attributes responsibility for PhIII delay to OWS
Ugur Sahin and his team at BioNTech have proffered more evidence that their Pfizer-partnered Covid-19 vaccine can protect people from a much-feared variant of SARS …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.